Nanodecal | About

About Us

Home
About Us

Respiratory superbugs

Pseudomonas aeruginosa is a type of bacteria that can infect people with long-term lung problems. If it isn’t quickly treated with the right antibiotics, the bacteria can form protective layers called biofilms. These biofilms make the infection very hard to get rid of.

Over 400 million at risk worldwide

People with COPD and bronchiectasis are especially vulnerable to respiratory superbugs.

Repeated hospital visits

Respiratory superbugs that are not treated with the right antibiotic can cause permanent lung damage, increasing healthcare costs.

PaST Kit: Rapid testing at the point of care

Nanodecal brings the first diagnostic kit that detects bacteria in sputum on the spot, right during your consultation. A reagent liquefies the sample, and a rapid test detects bacteria. These kits can be used anywhere in healthcare, making them ideal for guiding antibiotic treatments.

Faster than the standard of care

Culturing sputum takes several days. Nanodecal offers the first diagnostic kit to identify bacteria in sputum during the time required for a consultation.

Enabling precision

Nanodecal’s rapid test identifies bacteria quickly at the doctor's office, enabling the early administration of personalized treatments

Swiftlys® Sample liquefaction for decentralized analyses

Sputum, which contains bacteria that cause lung infections, is thick and nearly solid, making point-of-care analysis difficult. Nanodecal solves this problem with a reagent that liquefies sputum in just 2 minutes. Patent WO2021224529A1

In the consultation room

Swiftlys® does not require laboratory equipment.

Versatile

Compatible with different antigen test formats.

A new antigen test for rapid lung diagnosis

Antibody-coated nanoparticles are contact-transferred, overcoming the limitations of lateral flow tests. They are produced using our proprietary method, protected under patent WO2021048087A1.

Designed for high sensitivity and specificity

Thanks to the simultaneous detection of multiple antigens of the same pathogen.

Quick and Convenient

Results are obtained during the time required for a consultation.

Our Team

We are putting together a multidisciplinary team to bring Nanodecal's tech from bench to market.

Roberto de la Rica

CEO | Founder

I am committed to help Nanodecal grow so that our technology can help patients. I am thrilled by the idea of guiding therapeutic decisions using scientific evidence obtained on the spot.

Steven M. Russell

Quality & Regulatory Affairs Manager

I am dedicated to developing and maintaining the quality management system and mananging regulatory affairs to support the growth of Nanodecal.

Stephanos Papaefstathiou

COO

With a strong foundation in public health, I am engaged in fostering teamwork and collaboration throughout Nanodecal's operations.

Isabel Pérez Guillén

CSO

I am deeply passionate about clinical microbiology and hold a PhD in the field, which underscores my commitment to supporting Nanodecal's growth and enhancing patient care